The notion “blood banking” refers to the process of blood donation, testing, processing and storing for further transfusion. The industry is shaped by several forces such as product and process innovation, product safety and cost containment. At present, the blood banking market is also driven by growth in the elderly population and healthcare expenditures, changes in regulatory requirements and new infections’ emergence.
The market is highly concentrated in developed countries, with especially fierce competition coming from substitute products’ manufacturers and suppliers. The improvement of blood transfusion safety and efficiency, and higher automation are amid the key current trends seen in the blood banking industry. Meantime, the Asia Pacific market mesmerises players based in other regions given its high growth potential.
The research reports found in the Catalogue offer up-to-date data on the blood banking market. The reports disclose the present market situation and limelight future market prospects and key factors affecting the industry. The research reports present strategic assessments of market players’ performance and include detailed profiles of top companies.
Publications found:
900
Sort by:
Global Apheresis Station Market Growth 2026-2032
US$ 3,660.00
The global Apheresis Station market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Apheresis stations specialize in...
May 2026
117 pages
Blood Processing Devices and Consumables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Devices, Consumables), By Usage (Red Blood Cells, Plasma, Platelets, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for blood processing devices and consumables is expected to expand from USD 46.57 billion in 2025 to USD 64.32 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.5...
May 2026
185 pages
Blood Transfusion Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blood Transfusion Devices Market is projected to grow from USD 4.97 Billion in 2025 to USD 6.97 Billion by 2031 at a 5.8% CAGR. These specialized medical tools, which include access cathete...
May 2026
180 pages
Global Cord Blood Storage Equipment Market Growth 2026-2032
US$ 3,660.00
The global Cord Blood Storage Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market f...
April 2026
124 pages
Tissue Banking Market Report by Product (Equipment, Media and Consumables), Application (Therapeutics, Medical Research, and Others), Tissue Type (Cardiovascular Tissue, Lung Tissue, Kidney Tissue, Pancreas Tissue, Liver Tissue, Eye Tissue, and Others), and Region 2026-2034
US$ 3,999.00
The global tissue banking market size reached USD 2.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2034, exhibiting a growth rate (CAGR) of 9.20% during...
April 2026
139 pages
Asia Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Asia Pacific donor blood component market is projected to grow significantly, reaching an estimated US$ 1,878.3 million by 2031, up from US$ 1,262.3 million in 2024, reflecting a compound annual g...
March 2026
189 pages
Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Europe Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 3,464.5 million by 2031, up from US$ 2,420.0 million in 2024, reflecting a compound annual growth...
March 2026
170 pages
Middle East & Africa Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The Middle East & Africa Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 525.2 million by 2031, up from US$ 384.6 million in 2024. This growth represents a c...
March 2026
180 pages
North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Blood Component Volume (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Immunosuppression (Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others), Oncology (Hematologic Malignancies and Solid Tumor Patients), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care during Chemotherapy, Surgery, and Others), Age Group (Adult and Child), and End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others)
US$ 3,450.00
The North America donor blood component market is projected to grow significantly, reaching an estimated US$ 8,048.4 million by 2031, up from US$ 5,482.7 million in 2024, reflecting a compound annual...
March 2026
176 pages
